Useful resources |
HMG CoA reductase inhibitors (statins) for dialysis patients (Cochrane Review) ABSTRACT Background: Cardiovascular disease accounts for more than half the number of deaths among dialysis patients. The role of HMG CoA reductase inhibitors (statins) in the treatment of hyperlipidemia in dialysis patients is unclear and their safety has not been estab . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |